ALPK1 and Hyperglycemia: A recent paper has shown that Alpk1-overexpressed C57BL/6 mice exhibited a decreased insulin level and severe hyperglycaemia than wild type mice after streptozotocin (STZ) treatment (13), suggesting that Alpk1 might participate in the destruction of pancreatic beta cells.